The HSPB1 Knockout SK-HEP-1 Polyclonal Cells consist of a CRISPR/Cas9-edited polyclonal knockout cell population derived from the SK-HEP-1 human hepatocellular carcinoma line, providing a loss-of-function model for the study of HSPB1-dependent pathways. The polyclonal nature of the product circumvents clonal selection bias, offering a genetically diverse pool of edited cells suitable for functional screening and mechanistic analyses. This model enables researchers to assess the consequences of HSPB1 gene disruption in a liver cancer context without the constraints of a single clone.
The host SK-HEP-1 cell line originates from ascites-derived human liver adenocarcinoma and serves as an established model of hepatocellular carcinoma (HCC). SK-HEP-1 cells retain epithelial characteristics and are widely employed in studies of HCC biology, including tumor growth, metastasis, and therapeutic response. Their ascitic derivation suggests a metastatic phenotype, making this line particularly relevant for investigations of cancer cell migration, invasion, and chemoresistance.
HSPB1 (Hsp27) is a stress-responsive molecular chaperone that confers cytoprotection through multiple mechanisms. Under cellular stress conditions such as heat shock, oxidative stress, or exposure to cytokines (TNF-??, IL-6, TGF-??), HSPB1 is phosphorylated by the p38 MAPK/MK2 cascade. Phosphorylation promotes oligomerization and interaction with actin, thereby regulating cytoskeletal dynamics. In parallel, HSPB1 binds cytochrome c and DAXX, inhibiting apoptosome assembly and subsequent caspase-3 activation, while also modulating NF-??B signaling via Akt-mediated pathways and influencing Bcl-2 family protein expression. These interactions position HSPB1 at the intersection of stress response, apoptosis, and cytoskeletal regulation.
In hepatocellular carcinoma, elevated HSPB1 levels correlate with enhanced cell survival, chemoresistance, and tumor progression. The knockout of HSPB1 in SK-HEP-1 cells provides a platform to dissect its role in promoting sorafenib resistance and epithelial-mesenchymal transition. By eliminating HSPB1 expression, researchers can examine downstream effects on p38 MAPK-driven stress signaling, NF-??B-dependent transcription, and actin-mediated cell motility. This model also holds relevance for exploring the pathogenic mechanisms of HSPB1 mutations linked to Charcot-Marie-Tooth disease type 2F and distal hereditary motor neuropathy, though its primary utility lies in cancer biology.
Typical applications of these polyclonal knockout cells include Western blotting and RT-qPCR to verify HSPB1 disruption, apoptosis assays (e.g., caspase-3 activation, cytochrome c release) to study stress-induced cell death, and wound healing assays to assess migration. Immunofluorescence can visualize actin cytoskeleton reorganization, while co-immunoprecipitation probes interactions with partners such as DAXX, Hsp70, and ??-B-crystallin. Sorafenib sensitivity assays and phospho-p38 MAPK analysis facilitate chemoresistance and signaling studies. This product is suited for drug screening, liver cancer progression models, and investigations into HSPB1-related pathobiology. For further information, please contact Ascent Research.
